Extendicare Inc. (TSE:EXE – Get Free Report)’s share price hit a new 52-week high on Friday . The company traded as high as C$24.96 and last traded at C$24.73, with a volume of 28917 shares changing hands. The stock had previously closed at C$24.66.
Wall Street Analysts Forecast Growth
EXE has been the subject of a number of recent research reports. BMO Capital Markets upgraded Extendicare from a “hold” rating to an “outperform” rating and increased their target price for the company from C$21.00 to C$24.00 in a research note on Thursday, December 4th. National Bank Financial increased their price target on shares of Extendicare from C$24.50 to C$29.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Royal Bank Of Canada raised Extendicare from a “hold” rating to a “moderate buy” rating and boosted their price objective for the company from C$15.00 to C$25.00 in a report on Thursday, December 4th. TD Securities increased their target price on Extendicare from C$15.00 to C$19.00 in a report on Thursday, November 13th. Finally, Cormark lifted their target price on Extendicare from C$25.00 to C$30.00 in a research report on Wednesday, December 3rd. Two research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of C$24.50.
Check Out Our Latest Research Report on Extendicare
Extendicare Stock Performance
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
See Also
- Five stocks we like better than Extendicare
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
